Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  2007-08-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.298.6.655PMID 17684188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological Therapy for Wegener’s Granulomatosis

  2012cited by this paper
• [Antineutrophil cytoplasmic antibodies].

  2011cited by this paper
• Evidence-Based Medicine: Levels of Evidence and Grades of Recommendation

  2007cited by this paper
• Azathioprine as compared to cyclophosphamide maintenance therapy for PR3-ANCA-associated vasculitis is associated with increased longterm relapse risk.

  2007cited by this paper
• Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.

  2006cited by this paper
• Antineutrophil cytoplasmic antibodies

  2006cited by this paper
• What place for the new biologics in the treatment of necrotising vasculitides.

  2006cited by this paper
• Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide

  2006cited by this paper
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

  2006cited by this paper
• Wegener’s granulomatosis: Is biologic therapy useful?

  2006cited by this paper
• Advances in the therapy of Wegener's granulomatosis

  2006cited by this paper
• Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

  2005cited by this paper
• Differential modulation of p38 mitogen activated protein kinase and STAT3 signalling pathways by infliximab and etanercept in intestinal T cells from patients with Crohn's disease.

  2005cited by this paper
• Randomized controlled trials in vasculitis associated with anti-neutrophil cytoplasmic antibodies

  2005cited by this paper
• Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

  2005cited by this paper
• Etanercept plus Standard Therapy for Wegener's Granulomatosis

  2005cited by this paper
• Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

  2005cited by this paper
• Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.

  2005cited by this paper
• Deaths Occurring During the First Year After Treatment Onset for Polyarteritis Nodosa, Microscopic Polyangiitis, and Churg-Strauss Syndrome: A Retrospective Analysis of Causes and Factors Predictive of Mortality Based on 595 Patients

  2005cited by this paper
• What is new in the therapy of ANCA-associated vasculitides? Take home messages from the 12th workshop on ANCA and systemic vasculitides.

  2005influential reference
• Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

  2005cited by this paper
• Current state of tumour necrosis factor α blockade in Wegener’s granulomatosis

  2005cited by this paper
• Immunosuppressive Therapy and Clinical Evolution in Forty‐nine Patients with Antineutrophil Cytoplasmic Antibody‐Associated Glomerulonephritis

  2005cited by this paper
• Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis

  2005cited by this paper
• Etanercept plus standard therapy for Wegener's granulomatosis.

  2005cited by this paper
• Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?

  2005cited by this paper
• Diverse effects of infliximab and etanercept on T lymphocytes.

  2005cited by this paper
• Wegener's granulomatosis: evolving concepts in treatment.

  2004cited by this paper
• The antineutrophil cytoplasmic antibody-associated vasculitides.

  2004cited by this paper
• Prolonged Treatment with Low-Dose Intravenous Pulse Cyclophosphamide May Reduce Rate of Relapse in ANCA-Associated Vasculitis

  2004cited by this paper
• Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout

  2004cited by this paper
• Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis.

  2004cited by this paper
• Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.

  2004cited by this paper
• Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.

  2004cited by this paper
• Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.

  2004cited by this paper
• A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

  2003influential reference
• Plasma Exchange Treatment Improves Prognosis of Antineutrophil Cytoplasmic Antibody‐associated Crescentic Glomerulonephritis: A Case‐Control Study in 26 Patients from a Single Center

  2003cited by this paper
• Maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

  2003cited by this paper
• Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

  2003cited by this paper
• Maintenance of remission with leflunomide in Wegener's granulomatosis.

  2003cited by this paper
• Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.

  2003cited by this paper
• Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

  2003cited by this paper
• Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: a prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients.

  2003cited by this paper
• 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy.

  2003cited by this paper
• Clinical Outcome of Patients with Wegener’s Granulomatosis Treated with Plasma Exchange

  2002cited by this paper
• Design of the Wegener's Granulomatosis Etanercept Trial (WGET).

  2002cited by this paper
• High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.

  2002cited by this paper
• The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review.

  2001cited by this paper
• Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

  2001cited by this paper
• Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up.

  2001cited by this paper
• Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.

  2000cited by this paper
• An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

  2000cited by this paper
• Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.

  2000cited by this paper
• A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.

  1999cited by this paper
• Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.

  1999cited by this paper
• Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients.

  1999cited by this paper
• Microscopic polyangiitis (microscopic polyarteritis) with late emergence of generalised Wegener’s granulomatosis

  1999cited by this paper
• Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement.

  1999cited by this paper
• Induction of remission in Wegener's granulomatosis with low dose methotrexate.

  1998cited by this paper
• Wegener's granulomatosis: long-term follow-up of patients treated with pulse cyclophosphamide.

  1998cited by this paper
• Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.

  1998cited by this paper
• Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.

  1998cited by this paper
• A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

  1997cited by this paper
• Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.

  1997cited by this paper
• Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide

  1997cited by this paper
• Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides.

  1997cited by this paper
• Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis.

  1997cited by this paper
• Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients.

  1997cited by this paper
• Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis

  1996cited by this paper
• The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources.

  1996cited by this paper
• Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group.

  1996cited by this paper
• Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease.

  1996cited by this paper
• Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

  1996cited by this paper
• Monthly intravenous pulse cyclophosphamide therapy in Wegener's granulomatosis.

  1996cited by this paper
• Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole.

  1996cited by this paper
• Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis

  1996cited by this paper
• Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.

  1995cited by this paper
• Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin

  1995cited by this paper
• Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis.

  1995cited by this paper
• An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone.

  1995cited by this paper
• ANCA and predicting relapse in systemic vasculitis.

  1995cited by this paper
• Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.

  1994cited by this paper
• Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

  1994cited by this paper
• "Wegener's granulomatosis": the path traveled since 1931.

  1994cited by this paper
• Relapses in patients with a systemic vasculitis.

  1993cited by this paper
• Pooled intravenous immunoglobulin in the management of systemic vasculitis.

  1993cited by this paper
• Plasma Exchange Treatment in Rapidly Progressive Glomerulonephritis Associated with Antineutrophil Cytoplasmic Autoantibodies

  1992cited by this paper
• Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients.

  1992cited by this paper
• Wegener Granulomatosis: An Analysis of 158 Patients

  1992cited by this paper
• Pulse cyclophosphamide therapy in Wegener's granulomatosis: a pilot study

  1992cited by this paper
• The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

  1992cited by this paper
• Cyclophosphamide pulse therapy in Wegener's granulomatosis.

  1991cited by this paper
• Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa.

  1991cited by this paper
• Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies.

  1991cited by this paper
• Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network.

  1990cited by this paper
• Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide.

  1990cited by this paper
• The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision?

  1988cited by this paper
• Microscopic polyarteritis: presentation, pathology and prognosis.

  1985cited by this paper
• Wegener's granulomatosis: observations on treatment with antimicrobial agents.

  1985cited by this paper
• Wegener's granulomatosis. Clinical features and outcome in 13 patients.

  1983cited by this paper

• Simplifying ANCA-associated vasculitis classification with ANCA specificity: a retrospective analysis

  2025cites this paper
• Medication adherence and real-world factors of first line induction treatment selection in ANCA-associated vasculitis

  2025cites this paper
• Efficacy and Safety of Mepolizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis: A Single-Center Experience

  2024cites this paper
• Polyangiitis overlap syndrome: a rare clinical entity

  2023cites this paper
• Antineutrophil cytoplasmic antibody-associated vasculitis with alveolar hemorrhage and ruptured renal aneurysm

  2022cites this paper
• Current Evidence in the Diagnosis and Management of Coronary Arteritis Presenting as Acute Coronary Syndrome.

  2022cites this paper
• Granulomatosis with Polyangitis (GPA)

  2021cites this paper
• A Case of ANCA-Negative Limited Granulomatosis with Polyangiitis Presenting with Otitis Media

  2021cites this paper
• A Case of Eosinophilic Granulomatosis with Polyangiitis with Severe Peripheral Neuropathy Refractory to Standard Treatment SuccessfullyTreated by Mepolizumab

  2021cites this paper
• Antineutrophil Cytoplasmic Antibody-associated Vasculitis With Alveolar Hemorrhage and Ruptured Renal Aneurysm: a Case Report and Literature Review

  2021cites this paper
• A Week of Nightly Fevers in a 10-year-old Girl.

  2021cites this paper
• Granulomatosis with polyangiitis with severe lung involvement: efficacy of anti-B cell therapy with Rituximab

  2021cites this paper
• Atypical presentation of eosinophilic granulomatosis - typical presentation in an ageing population?

  2020cites this paper
• Manifestaciones imagenológicas pulmonares y abdominales de las vasculitis primarias

  2020cites this paper
• Accelerated corneal endothelial cell loss in two patients with granulomatosis with polyangiitis following phacoemulsification

  2020cites this paper
• Eosinophilic Granulomatosis With Polyangiitis Presenting as an Acute Coronary Syndrome

  2020cites this paper
• Eosinophilic granulomatosis with polyangiitis: Not all infiltrates are pneumonia

  2020cites this paper
• The role of plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis

  2020cites this paper
• Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen‐Year National Study

  2020cites this paper
• Cutaneous Manifestations of Granulomatosis with Polyangiitis: A Case Series Study

  2020cites this paper
• Management of ANCA associated vasculitis

  2020cites this paper
• Clinical outcome in pediatric refractory gastrointestinal Henoch-Schönlein purpura treated with mycophenolate mofetil

  2020cites this paper
• Interventions for renal vasculitis in adults.

  2020cites this paper
• Churg-Strauss Syndrome Presenting as Acute Necrotizing Eosinophilic Myocarditis: Concise Review of the Literature.

  2019cites this paper
• Chronic Eye Redness and Pain After 9 Months of Anti-inflammatory Therapy.

  2019cites this paper
• Severe mononeuritis multiplex in a patient with eosinophilic granulomatosis with polyangiitis

  2019cites this paper
• Heightened Immune Response to Presumed Loxosceles reclusa Envenomation

  2019cites this paper
• Seltene Ursache einer Hämoptyse

  2019cites this paper
• Eosinophilic Granulomatosis with Polyangiitis: The Beginning of a New Era

  2019cites this paper
• Seltene Ursache einer Hämoptyse

  2019cites this paper
• Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis

  2019cites this paper
• Corneal melt secondary to eosinophilic granulomatosis with polyangiitis

  2019cites this paper
• Non-infectious aortic and mitral valve vegetations in a patient with eosinophilic granulomatosis with polyangiitis

  2019cites this paper
• Successful treatment of steroid-refractory double-positive ANCA and anti-GBM disease with a combination of plasma exchange and immunosuppression: A case report and literature review

  2018influential citation
• Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States

  2018cites this paper
• Prognostic Significance of Cavitary Lung Nodules in Granulomatosis With Polyangiitis (Wegener's): A Clinical Imaging Study of 225 Patients

  2018cites this paper
• A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis

  2018cites this paper
• Vaskulitis und Vaskulopathien

  2018cites this paper
• Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis

  2018cites this paper
• Personalized medicine for connective tissue disease: Historical and future perspectives

  2018cites this paper
• Churg-Straus syndrome: A case report

  2017cites this paper
• Successful implementation of Rituximab in patients with severe refractory forms granulomatosis with poliangitis

  2017cites this paper
• Refractory skin lesion, hypertension and acute kidney injury in a young boy: Questions

  2017cites this paper
• Rathke's cleft cyst associated with pituitary granulomatosis with polyangiitis: An unusual combination of hypothalamus-pituitary region pathologies

  2017cites this paper
• Lesson of the month 1: Beware the atypical presentation: eosinophilic granulomatosis with polyangiitis presenting as acute coronary syndrome.

  2017cites this paper
• Paediatric anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: an update on renal management

  2017cites this paper
• Sjögren's Syndrome Parotid Irrigation and Cevimeline Gargle for Treatment of Xerostomia in

  2017cites this paper
• [Acute cerebral sinus-thrombosis due to polyangiitis overlap syndrome with granulomatosis with polyangiitis (Wegener's granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)].

  2016cites this paper
• Neutrophils Self-Regulate Immune Complex-Mediated Cutaneous Inflammation through CXCL2.

  2016cites this paper
• Extracorporeal membrane oxygenation rescue in adolescent with bronchiolitis obliterans‐organizing pneumonia like Wegener's granulomatosis

  2016cites this paper
• An interesting case of ANCA associated vasculitis

  2016cites this paper
• Not All Coughs Are Asthma or Allergies: Churg-Strauss Syndrome.

  2016cites this paper
• Pneumocystose chez les patients immunodéprimés non infectés par le VIH

  2016cites this paper
• Refractory skin lesion, hypertension, and acute kidney injury in a young boy: Answers

  2016cites this paper
• [Pneumocystosis in non-HIV-infected immunocompromised patients].

  2016cites this paper
• A 39-Year-Old Postpartum Woman With Foot Drop and Shortness of Breath.

  2016cites this paper
• Erosive rhinitis resembling granulomatosis with polyangiitis (Wegener's granulomatosis) in an Anatolian shepherd dog

  2015cites this paper
• Incidence of Cancer in ANCA-Associated Vasculitis: A Meta-Analysis of Observational Studies

  2015cites this paper
• Eosinophilic Granulomatosis With Polyangiitis (Churg–Strauss Syndrome) Presenting With Polyneuropathy—A Case Series

  2015cites this paper
• Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States

  2015cites this paper
• Clinical Features of Children with Pulmonary Microscopic Polyangiitis: Report of 9 Cases

  2015cites this paper
• Factors that predict in‐hospital mortality in eosinophilic granulomatosis with polyangiitis

  2015cites this paper
• Wegener's Granulomatosis with Nervous System Involvement: A Hospital-Based Study

  2015cites this paper
• Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report

  2015cites this paper
• Churg-Strauss syndrome from an orthopaedic perspective.

  2015cites this paper
• Epidemiology and Pathophysiology of Chronic Rhinosinusitis

  2015cites this paper
• Childhood ANCA Positive Eosinophilic Granulomatosis with Polyangiitis

  2015cites this paper
• Interventions for renal vasculitis in adults.

  2015cites this paper
• Clinical analysis of ANCA-associated renal vasculitis patients with chronic dialysis.

  2014cites this paper
• Clinical and Pathological Features of Microscopic Polyangiitis in 20 Children

  2014cites this paper
• Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis)

  2014cites this paper
• Non-biologic remission maintenance therapy in adult patients with ANCA-associated vasculitis: a systematic review and network meta-analysis.

  2014cites this paper
• Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis

  2014cites this paper
• A Case of Antineutrophil Cytoplasmic Antibody-negative Granulomatosis with Polyangiitis Presenting as Breast Mass

  2014cites this paper
• An uncommon presentation of eosinophilic granulomatosis with polyangiitis: a case report

  2014cites this paper
• Hydralazine associated pauci-immune glomerulonephritis.

  2014cites this paper
• Maintien de la rémission sans biothérapie chez les patients adultes atteints de vascularite à ANCA : revue systématique de la littérature et méta-analyse en réseau

  2014cites this paper
• Targeting B Cells in ANCA-Associated Vasculitides

  2014cites this paper
• [A man in his 60's with chest pain with chest pain and functional dyspnea].

  2014cites this paper
• An Unusual Case of Hematuria

  2014influential citation
• Severe asthma: definition, diagnosis and treatment.

  2014cites this paper
• Cerebral vasculitis.

  2014cites this paper
• Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis

  2013cites this paper
• AP-VAS 2012 case report: a case of lupus nephritis with predominant synchronous cellular crescent formation and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity

  2013influential citation
• [Current indications of azathioprine in nephrology].

  2013cites this paper
• Cerebral vasculitis

  2013cites this paper
• Table 1182 Chest Pain and SLE in the Emergency Department : Common Causes , Workup , and Treatment

  2013cites this paper
• Children with life-threatening pulmonary haemorrhage

  2013cites this paper
• Plasma exchange in the treatment of rapidly progressive glomerulonephritis.

  2013cites this paper
• ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships.

  2013cites this paper
• A Case of ANCA-Negative Generalized Wegener's Granulomatosis

  2013cites this paper
• AP-VAS 2012 case report: a case of ANCA-negative crescentic glomerulonephritis complicating multiple opportunistic infections in the digestive tract

  2013cites this paper
• DIAGNOSTIC DIFFICULTIES IN A CASE OF systemic vasculitis

  2013cites this paper
• Hydralazine-induced anti-neutrophil cytoplasmic antibody-positive renal vasculitis presenting with a vasculitic syndrome, acute nephritis and a puzzling skin rash: a case report

  2013cites this paper
• Syndrome pneumo-rénal : une urgence diagnostique et thérapeutique pour le réanimateur et l’interniste

  2013cites this paper
• Rituximab for ANCA-associated vasculitis in the setting of severe infection

  2013influential citation
• [The pulmonary-renal syndrome: a diagnostic and therapeutic emergency for the internist and the intensivist].

  2013cites this paper
• Indications actuelles de l’azathioprine en néphrologie

  2013cites this paper
• Is it acute coronary syndrome or Churg-Strauss syndrome?

  2013cites this paper
• 再燃した肺胞出血に対し血漿交換療法が著効したChurg-Strauss syndromeの一例

  2012cites this paper